|
冠状动脉三支病变的易患因素及相关预测指标分析
|
Abstract:
[1] | Ribichini, F., Romano, M., Rosiello, R., et al. (2013) A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients with Multivessel Coronary Artery Disease: The Executive Trial (Executive RCT: Evaluating XIENCE V in a Multi Vessel Disease). JACC: Cardiovascular Interventions, 6, 1012-1022. https://doi.org/10.1016/j.jcin.2013.05.016 |
[2] | Hamza, M., Mahmoud, N. and Elgendy, I.Y. (2016) A Randomized Trial of Complete versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease. Journal of Interventional Cardiology, 29, 241-247.
https://doi.org/10.1111/joic.12293 |
[3] | 牛海芳, 车京津, 邵元霞, 甘慧敏. 早发严重冠状动脉三支病变患者冠心病危险因素的分布及聚集[J]. 天津医药, 2011, 39(5): 402-405. |
[4] | 余吉仙, 盛吉芳. HBV阳性原发性肝癌的高危因素探讨[J]. 中国微生态学杂志, 2010(4): 81-82 + 84. |
[5] | 田声放, 李长贵, 康维强, 等. 冠心病患者冠状动脉病变与糖耐量变化的关系[J]. 中华内分泌代谢杂志, 2002, 18(4): 289-292. |
[6] | American Diabetes Association (2018) Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018. Diabetes Care, 41, S86-S104. https://doi.org/10.2337/dc18-S009 |
[7] | Lin, L., Jin, C., Wei, X., et al. (2015) Comparison on the Efficacy of Everolimus-Eluting Stent and Zotarolimus-Eluting Stents in Coronary Heart Disease between Diabetic and Non-Diabetic Patients. International Journal of Clinical and Experimental Medicine, 8, 20813-20820. |
[8] | Penna, C., Andreadou, I., Aragno, M., Beauloye, C., Bertrand, L., Lazou, A., et al. (2020) Effect of Hyperglycaemia and Diabetes on Acute Myocardial Ischaemia-Reperfusion Injury and Cardioprotection by Ischaemic Conditioning Protocols. British Journal of Pharmacology. https://doi.org/10.1111/bph.14993 |
[9] | Henning, R.J. (2018) Type-2 Diabetes Mellitus and Cardiovascular Disease. Future Cardiology, 14, 491-509.
https://doi.org/10.2217/fca-2018-0045 |
[10] | Ebrahim, M.E.B.M., Dignan, R., Femia, G., et al. (2019) Late Clinical Outcomes of Unselected Patients with Diabetic Mellitus and Multi-Vessel Coronary Artery Disease. International Journal of Cardiology, 296, 21-25.
https://doi.org/10.1016/j.ijcard.2019.07.038 |
[11] | 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国心血管病预防指南[J]. 中华心血管病杂志, 2011, 39(1): 3-22. |
[12] | Kokubo, Y. and Matsumoto, C. (2017) Hypertension Is a Risk Factor for Several Types of Heart Disease: Review of Prospective Studies. Advances in Experimental Medicine and Biology, 956, 419-426.
https://doi.org/10.1007/5584_2016_99 |
[13] | Zhang, J.X., Dong, H.Z., Chen, B.W., et al. (2016) Characteristics of Coronary Arterial Lesions in Patients with Coronary Heart Disease and Hypertension. Springerplus, 5, 1208. https://doi.org/10.1186/s40064-016-2828-7 |
[14] | Buljubasic, N., Akkerhuis, K.M., deBoer, S.P., et al. (2015) Smoking in Relation to Coronary Atherosclerotic Plaque Burden, Volume and Composition on Intravascular Ultrasound. PLoS ONE, 10, e0141093.
https://doi.org/10.1371/journal.pone.0141093 |
[15] | Yano, M., Miura, S., Shiga, Y., et al. (2016) Association between Smoking Habits and Severity of Coronary Stenosis as Assessed by Coronary Computed Tomography Angiography. Heart Vessels, 31, 1061-1068.
https://doi.org/10.1007/s00380-015-0716-7 |
[16] | Hoo, F.K., Foo, Y.L., Lim, S.M., et al. (2016) Acute Coronary Syndrome in Young Adults from a Malaysian Tertiary Care Centre. Pakistan Journal of Medical Sciences, 32, 841-845. https://doi.org/10.12669/pjms.324.9689 |
[17] | Reiner, Z., Catapano, A.L., De Backer, G., et al. (2011) ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). European Heart Journal, 32, 1769-1818. https://doi.org/10.1093/eurheartj/ehr158 |
[18] | 高洁, 耿晓雯, 吕中华, 等. 冠状动脉多支病变的危险因素分析[J]. 解放军医学院学报, 2016, 37(5): 413-416, 420. |
[19] | 徐雪晶, 洪雪娇, 王朝阳, 陈联发. NT-proBNP、hs-CRP、Hcy联合超声心动图在急性心肌梗死疾病的诊断及预后中的价值[J]. 中国医药科学, 2019, 9(24): 36-39. |
[20] | de Lemos, J.A. and Morrow, D.A. (2002) Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes: Ready for Clinical Application. Circulation, 106, 2868-2870. https://doi.org/10.1161/01.CIR.0000042763.07757.C0 |
[21] | Itakura, R., Inoue, Y., Ogawa, K., et al. (2020) A Highly-Sensitized Response of B-Type Natriuretic Peptide to Cardiac Ischaemia Quantified by Intracoronary Pressure Measurements. Scientific Reports, 10, Article No. 2403.
https://doi.org/10.1038/s41598-020-59309-4 |
[22] | Hama, N., Itoh, H., Shirakami, G., et al. (1995) Rapid Ventricular Induction of Brain Natriuretic Peptide Gene Expression in Experimental Acute Myocardial Infarction. Circulation, 92, 1558-1564.
https://doi.org/10.1161/01.CIR.92.6.1558 |
[23] | 蓝运竞, 杨成明, 王旭开, 等. 联合踝臂指数和钙化积分判定老年冠脉3支病变的价值[J]. 心脏杂志, 2009(3): 403-406. |
[24] | Iskandrian, A.S., Heo, J., Lemlek, J. and Ogilby, J.D. (1993) Identification of High-Risk Patients with Left Main and Three-Vessel Coronary Artery Disease Using Stepwise Discriminant Analysis of Clinical, Exercise, and Tomographic Thallium Data. American Heart Journal, 125, 221-225. https://doi.org/10.1016/0002-8703(93)90078-N |
[25] | Kosuge, M., Kimura, K. and Ishikawa, T. (2005) Predictors of Left Main or Three-Vessel Disease in Patients Who Have Acute Coronary Syndromes with Non-ST-Segment Elevation. American Journal of Cardiology, 95, 1366-1369.
https://doi.org/10.1016/j.amjcard.2005.01.085 |